Ramona, CA, United States of America

Daniel Kolk

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Kolk

Introduction

Daniel Kolk is a prominent inventor based in Ramona, California, known for his significant contributions to the field of virology. With a total of 17 patents to his name, Kolk has made remarkable advancements in the detection and quantification of human parainfluenza viruses.

Latest Patents

Kolk's latest patents include innovative compositions and methods for detecting or quantifying Human Parainfluenza Virus 4. These patents provide compositions, methods, kits, and uses for detecting or quantifying HPIV-1, HPIV-2, HPIV-3, and HPIV-4 nucleic acids, utilizing nucleic acid amplification and hybridization assays. In some embodiments, the compositions target the HN gene of HPIV-1, HPIV-2, and HPIV-3, as well as the NP gene of HPIV-4. Additionally, he has developed similar compositions and methods for detecting or quantifying Human Parainfluenza Virus 2, further showcasing his expertise in this critical area of research.

Career Highlights

Kolk is currently associated with Gen-Probe, Inc., where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in enhancing the understanding and detection of parainfluenza viruses, which are significant pathogens in human health.

Collaborations

Throughout his career, Kolk has collaborated with notable colleagues, including Mehrdad R Majlessi and Pamela Douglass. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Daniel Kolk's innovative work in the field of virology, particularly in the detection of human parainfluenza viruses, has established him as a leading inventor. His contributions continue to impact the scientific community and improve public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…